Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$81,586,053
-$11,376,836 QoQ
Shares Held
271,023
-3.5% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#59
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Derivatives in ALNY
reported options exposure · as of Dec 31, 2023CallValue
$0
CallShares
0
PutValue
$9,570
PutShares
50
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $3,275,701,265 across 414 Biotechnology names. ALNY ranks #9 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
4,377,120 | $306,529,713 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
399,847 | $249,320,598 | |
| 3 | ARGX |
Argenx SE
|
157,958 | $146,548,693 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
262,258 | $130,271,416 | |
| 5 | BNTX |
BioNTech SE
|
1,319,517 | $122,781,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
552,710 | $103,511,528 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
1,079,015 | $102,689,857 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,155,442 | $86,057,320 |
All Filings in ALNY
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81,586,053 | 271,023 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $92,962,889 | 280,965 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $154,858,827 | 389,435 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $69,785,784 | 153,039 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $41,946,261 | 128,634 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,496,101 | 42,575 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $9,816,662 | 41,718 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $31,569,043 | 114,784 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $30,620,916 | 126,012 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $15,161,104 | 101,446 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $15,830,372 | 82,704 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $9,570 | 50 | Put | Defined | 2024-02-14 | |
| 2023-09-30 | $9,103,471 | 51,403 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $8,855 | 50 | Put | Defined | 2023-11-14 | |
| 2023-06-30 | $7,328,075 | 38,581 | Shares | Defined | 2023-08-09 | |
| 2023-06-30 | $59,071 | 311 | Put | Defined | 2023-08-09 | |
| 2023-03-31 | $14,239,346 | 71,083 | Shares | Defined | 2023-05-12 | |
| 2023-03-31 | $70,311 | 351 | Put | Defined | 2023-05-12 | |
| 2022-12-31 | $6,680,579 | 28,111 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $17,884,296 | 89,350 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $8,331,097 | 57,121 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,891,443 | 66,700 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $11,195,502 | 66,019 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $14,572,544 | 77,181 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $3,396,672 | 20,037 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $3,387,854 | 23,995 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $4,944,708 | 38,045 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $5,366,961 | 36,861 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $7,547,685 | 50,960 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $6,005,144 | 55,169 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||